Compositions and methods for therapeutic delivery with frozen particles

• US 20100111836A1
• Filed: 02/26/2009
• Published: 05/06/2010
• Est. Priority Date: 10/31/2008
• Status: Abandoned Application

• Current Assignee: Gearbox LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Myhrvold, Nathan P., Boyden, Edward S., Wood, Lowell L. JR., Hyde, Roderick A., Sweeney, Elizabeth A., Leuthardt, Eric C.
• Application Number:
  US12/380,566
• Publication Number:
  US 20100111836A1
• Time in Patent Office: Days
• US Class Current: 424/1.110
• CPC Class Codes: A61K 2039/505 comprising antibodies
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/00 Medicinal preparations containing organic active ingredients
• CPC Class Codes: A61K 31/10 Sulfides; Sulfoxides; Sulfones
• CPC Class Codes: A61K 31/337 having four-membered rings, e.g. taxol
• CPC Class Codes: A61K 31/505 Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
• CPC Class Codes: A61K 31/70 Carbohydrates; Sugars; Derivatives thereof sorbitol A61K31/047
• CPC Class Codes: A61K 31/7012 Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid gluconic acid A61K31/191; ascorbic acid A61K31/375
• CPC Class Codes: A61K 31/7088 Compounds having three or more nucleosides or nucleotides
• CPC Class Codes: A61K 33/00 Medicinal preparations containing inorganic active ingredients
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61K 39/395 Antibodies agglutinins A61K38/36 ; as drug carriers A61K47/50; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
• CPC Class Codes: A61K 41/0004 Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: A61K 49/1818 particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
• CPC Class Codes: A61K 51/12 characterised by a special physical form, e.g. emulsion, microcapsules, liposomes , characterized by a special physical form, e.g. emulsions, dispersions, microcapsules liposomes A61K51/1234
• CPC Class Codes: A61K 51/1244 microparticles or nanoparticles, e.g. polymeric nanoparticles
• CPC Class Codes: A61K 9/0019 Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner non-active ingredients are additionally classified in A61K47/00
• CPC Class Codes: A61K 9/0021 Intradermal administration, e.g. through microneedle arrays, needleless injectors mechanical aspects A61M
• CPC Class Codes: A61K 9/007 Pulmonary tract; Aromatherapy
• CPC Class Codes: A61K 9/08 : Solutions composition of solutions A61K47/00
• CPC Class Codes: A61K 9/127 : Liposomes
• CPC Class Codes: A61K 9/1611 : Inorganic compounds
• CPC Class Codes: A61K 9/1641 : obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
• CPC Class Codes: A61K 9/1664 : Compounds of unknown constitution, e.g. material from plants or animals oils, fats, waxes, shellac A61K9/1617
• CPC Class Codes: A61K 9/1688 : resulting in pure drug agglomerate optionally containing up to 5% of excipient
• CPC Class Codes: A61K 9/19 : lyophilised , i.e. freeze-dried, solutions or dispersions lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00
• CPC Class Codes: C07K 16/2863 : against receptors for growth factors, growth regulators

Abstract

Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

Claims

1-40. -40. (canceled)

41. A method of providing at least one therapeutic agent to at least one biological tissue of a subject, comprising:

delivering at least one therapeutic composition to at least one biological tissue, wherein the at least one therapeutic composition includes one or more frozen particles including at least one therapeutic agent and at least one of polyethylene glycol, acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, hexamethylphosphorotriamide, perfluorohydrocarbon, methanol, ethanol, tert-butyl alcohol, formic acid, hydrogen fluoride, ammonia, acetic acid, benzene, carbon tetrachloride, acetonitrile, hexane, methylene chloride, carboxylic acid, saline, Ringer'"'"'s solution, lactated Ringer'"'"'s solution, Hartmann'"'"'s solution, acetated Ringer'"'"'s solution, phosphate buffered solution, TRIS-buffered saline solution, Hank'"'"'s balanced salt solution, Earle'"'"'s balanced salt solution, standard saline citrate, HEPES-buffered saline, dextrose, glucose, or diethyl ether.

45. The method of claim 41, wherein delivering at least one therapeutic composition to at least one biological tissue includes propelling the therapeutic composition toward the at least one biological tissue.

48. The method of claim 45, wherein the at least one therapeutic composition is propelled to a predetermined velocity for delivery of the at least one therapeutic composition to a desired location of the at least one biological tissue.

50. The method of claim 41, wherein delivering at least one therapeutic composition includes ejecting the therapeutic composition toward at least one biological tissue.

51. The method of claim 41, wherein delivering at least one therapeutic composition includes accelerating the therapeutic composition toward at least one biological tissue.

52. The method of claim 51, wherein the at least one therapeutic composition is accelerated to a predetermined velocity for delivery of the at least one therapeutic composition to a desired location of the at least one biological tissue.

54. The method of claim 41, wherein delivering at least one therapeutic composition to at least one biological tissue includes propelling, ejecting or accelerating a plurality of therapeutic compositions toward the at least one biological tissue.

59. The method of claim 41, wherein delivering the at least one therapeutic composition occurs prior to, during, or subsequent to surgery.

60. The method of claim 41, wherein the at least one biological tissue is located in at least one of in situ, in vitro, in vivo, in utero, in planta, in silico, or ex vivo.

62. The method of claim 60, wherein the at least one biological tissue is transplanted or implanted into at least one subject.

63. The method of claim 60, wherein the at least one biological tissue is ingested by at least one subject.

64. The method of claim 60, wherein the at least one biological tissue includes at least one biological tissue from at least one donor or recipient.

65. The method of claim 64, wherein at least one donor includes at least one cadaver.

67. The method of claim 60, wherein the at least one biological tissue includes at least one cell mass.

69. The method of claim 67, wherein the at least one cell mass includes at least one benign or malignant tumor.

72. The method of claim 41, further comprising delivering to the at least one biological tissue at least one of a polymer, biopolymer, nanoparticle, or detection material.

76. The method of claim 72, wherein the detection material includes at least one electronic identification device.

77. The method of claim 76, wherein the at least one electronic identification device includes at least one radio frequency identification device.

78. The method of claim 72, wherein the detection material includes at least one radioactive element.

80. The method of claim 72, wherein the detection material includes at least one colorimetric substance.

82. The method of claim 80, wherein the at least one colorimetric substance includes one or more of a dye, pigment, or light-emitting substance.

83. The method of claim 82, wherein the light-emitting substance includes at least one of a fluorescent substance, phosphorescent substance, or quantum dot.

85. The method of claim 72, wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle.

86. The method of claim 41, wherein the subject includes at least one invertebrate or vertebrate animal.

88. The method of claim 41, wherein the subject includes at least one human.

89. The method of claim 86, wherein the subject includes at least one of livestock, pet, undomesticated herd animal, wild animal, or a product animal.

91. The method of claim 41, wherein the at least one therapeutic composition further comprises one or more reinforcement agents.

92. The method of claim 41, wherein the at least one therapeutic composition further comprises one or more explosive materials.

42-44. -44. (canceled)

46-47. -47. (canceled)

49. (canceled)

53. (canceled)

55-58. -58. (canceled)

61. (canceled)

66. (canceled)

68. (canceled)

70-71. -71. (canceled)

73-75. -75. (canceled)

79. (canceled)

81. (canceled)

84. (canceled)

87. (canceled)

90. (canceled)

93. A method of vaccinating a subject, comprising:

delivering to at least one biological tissue of a subject at least one therapeutic composition;

wherein the at least one therapeutic composition includes one or more frozen particles including at least one vaccine and including at least one of polyethylene glycol, acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, hexamethylphosphorotriamide, perfluorohydrocarbon, methanol, ethanol, tert-butyl alcohol, formic acid, hydrogen fluoride, ammonia, acetic acid, benzene, carbon tetrachloride, acetonitrile, hexane, methylene chloride, carboxylic acid, saline, Ringer'"'"'s solution, lactated Ringer'"'"'s solution, Hartmann'"'"'s solution, acetated Ringer'"'"'s solution, phosphate buffered solution, TRIS-buffered saline solution, Hank'"'"'s balanced salt solution, Earle'"'"'s balanced salt solution, standard saline citrate, HEPES-buffered saline, dextrose, glucose, or diethyl ether.

97. The method of claim 93, wherein the at least one vaccine includes at least one anti-cancer vaccine.

99. The method of claim 93, further comprising at least one adjuvant.

102. The method of claim 93, wherein delivering at least one therapeutic composition to at least one biological tissue includes propelling the therapeutic composition toward the at least one biological tissue.

107. The method of claim 93, wherein delivering at least one therapeutic composition includes ejecting the therapeutic composition toward at least one biological tissue.

108. The method of claim 93, wherein delivering at least one therapeutic composition to at least one biological tissue includes accelerating the therapeutic composition toward at least one biological tissue.

111. The method of claim 93, wherein delivering at least one therapeutic composition to at least one biological tissue includes propelling, ejecting, or accelerating a plurality of therapeutic compositions toward the at least one biological tissue.

116. The method of claim 93, wherein delivering the at least one therapeutic composition occurs prior to, during, or subsequent to surgery.

117. The method of claim 93, wherein the at least one biological tissue is located in at least one of in situ, in vitro, in vivo, in utero, in planta, in silico, or ex vivo.

119. The method of claim 117, wherein the at least one biological tissue is transplanted or implanted into at least one subject.

120. The method of claim 117, wherein the at least one biological tissue is ingested by at least one subject.

121. The method of claim 117, wherein the at least one biological tissue includes at least one biological tissue from at least one donor or recipient.

124. The method of claim 117, wherein the at least one biological tissue includes at least one cell mass.

126. The method of claim 124, wherein the at least one cell mass includes at least one benign or malignant tumor.

129. The method of claim 93, further comprising delivering to the at least one biological tissue at least one of a polymer, biopolymer, nanoparticle, or detection material.

133. The method of claim 129, wherein the detection material includes at least one electronic identification device.

134. The method of claim 133, wherein the at least one electronic identification device includes at least one radio frequency identification device.

135. The method of claim 129, wherein the detection material includes at least one radioactive element.

137. The method of claim 129, wherein the detection material includes at least one colorimetric substance.

139. The method of claim 137, wherein the at least one colorimetric substance includes one or more of a dye, pigment, or light-emitting substance.

142. The method of claim 129, wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle.

143. The method of claim 93, wherein the subject includes at least one invertebrate or vertebrate animal.

145. The method of claim 93, wherein the subject includes at least one human.

146. The method of claim 145, wherein the subject includes at least one of livestock, pet, undomesticated herd animal, wild animal, or a product animal.

148. The method of claim 93, wherein the at least one therapeutic composition further comprises one or more reinforcement agents.

149. The method of claim 93, wherein the at least one therapeutic composition further comprises one or more explosive materials.

94-96. -96. (canceled)

98. (canceled)

100-101. -101. (canceled)

103-106. -106. (canceled)

109-110. -110. (canceled)

112-115. -115. (canceled)

118. (canceled)

122-123. -123. (canceled)

125. (canceled)

127-128. -128. (canceled)

130-132. -132. (canceled)

136. (canceled)

138. (canceled)

140-141. -141. (canceled)

144. (canceled)

147. (canceled)